IMMIX BIOPHARMA INC.
1.6500
26-November-24 16:45:00
15 minutes delayed
Stocks
-0.0700
-4.07%
Today's range
1.6400 - 1.7801
ISIN
N/A
Source
NASDAQ
-
10 Jul 2023 09:47:00 By Nasdaq GlobeNewswire
-
Immix Biopharma Subsidiary Nexcella Completes Pre-IND Meeting with FDA on NXC-201 US Clinical Trial
26 Jun 2023 09:49:00 By Nasdaq GlobeNewswire
-
22 Jun 2023 09:53:00 By Nasdaq GlobeNewswire
-
20 Jun 2023 09:45:00 By Nasdaq GlobeNewswire
-
16 Jun 2023 09:43:00 By Nasdaq GlobeNewswire
-
Immix Biopharma Completes $5 Million At-The-Market Equity Offering Program
14 Jun 2023 07:30:00 By Nasdaq GlobeNewswire
-
12 Jun 2023 09:49:00 By Nasdaq GlobeNewswire
-
26 May 2023 09:53:00 By Nasdaq GlobeNewswire
-
04 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
23 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
Immix Biopharma Confirms No Exposure to Silicon Valley Bank or Silvergate Bank
10 Mar 2023 19:45:20 By Nasdaq GlobeNewswire
-
06 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
27 Feb 2023 08:45:00 By Nasdaq GlobeNewswire
-
15 Feb 2023 08:30:00 By Nasdaq GlobeNewswire